Showing results (171-180 of 287) with videos related to
Sort By:
Pageof 29
Annals of Clinical and Translational Neurology|March 28, 2026
GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological PracticeAndrew McKeon, Dana Olofson, Diana Anissian, et al.European Journal of Neurology|March 11, 2024
Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profilesGeorgios Mangioris, Thorvardur R Halfdanarson, Vanda A Lennon, et al.Epilepsia|January 15, 2022
CASPR2-IgG-associated autoimmune seizuresEmilio R Garrido Sanabria, Anza Zahid, Jeffrey Britton, et al.Neurology. Education|January 3, 2025
Curriculum Innovations: A Novel Neurology Clinician-Educator ProgramRafid Mustafa, Sherri A Braksick, Jeremy K Cutsforth-Gregory, et al.Neurology|August 16, 2020
Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomesElia Sechi, Svetomir N Markovic, Andrew McKeon, et al.Journal of Neuroimmunology|September 11, 2018
Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunctionDivyanshu Dubey, Naga Kothapalli, Andrew McKeon, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2018
Population-based study of "no evident disease activity" in MSNatalie E Parks, Sean J Pittock, Jay Mandrekar, et al.JAMA Neurology|November 11, 2014
Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disordersEoin P Flanagan, Brian G Weinshenker, Karl N Krecke, et al.Annals of Clinical and Translational Neurology|February 4, 2025
Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assayYana Said, Angeliki Filippatou, Conlan Tran, et al.Epilepsia|June 27, 2023
Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodiesKelsey M Smith, Jeffrey W Britton, Smathorn Thakolwiboon, et al.Pageof 29